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ABSTRACT
Central giant cell granuloma is an uncommon benign intraosseus lesion of jaws. Traditional treatment has been local 
curettage, although aggressive sub-types have a high tendency to recur. This patient report describes a recurrent central 
giant cell granuloma involving the body of the mandible in a 48-year-old-woman. Initial treatment of lesion consisted 
of curettage and peripheral ostectomy. When recurrence was detected one year later, an en bloc resection and defect re-
generation with a composite bone graft of autogenous bone, xenograft, and autologous platelet-rich plasma was carried 
out. Adequate new bone formation was observed during follow-up of 24 months. Two dental implants were placed, and 
implant-supported prosthesis was constructed, providing a satisfactory dental restoration.
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RESUMEN
El granuloma central de células gigantes es una rara lesión intraósea benigna de los maxilares. El tratamiento tradicional 
ha sido el curetaje local, aunque los sub-tipos agresivos tienen una alta tendencia a la recurrencia. Este caso clínico describe 
un granuloma central de células gigantes recurrente en el cuerpo mandibular de una mujer de 48 años. El tratamiento 
inicial de la lesión consistió en un curetaje con ostectomía periférica. Cuando se detectó la recurrencia un año más tarde, 
se realizó una resección ósea en bloque y la regeneración del defecto con un injerto óseo compuesto de hueso autógeno, 
xenoinjerto y plasma rico en plaquetas autólogo. A los 24 meses de seguimiento se observó una adecuada formación de 
hueso nuevo. Se insertaron dos implantes dentales y se construyó una prótesis implanto-soportada, proporcionando un 
restauración dentaria satisfactoria.
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INTRODUCTION
Central giant cell granuloma (CGCG) is an uncommon be-
nign intraosseus lesion that occurs almost exclusively in jaws, 
introduced for the first time by Jaffé in 1953 (1). Although its 
aetiology and pathogenesis is even unknown, its histology and 
clinical behaviour has been studied in detail (2-5). Recently the 
World Health Organization has defined it as localized benign 
but sometimes aggressive osteolytic proliferation consisting 
of fibrous tissue with haemorrhage and haemosiderin depo-
sits, presence of osteoclast-like giant cells and reactive bone 
formation (6). Many authors have established the differences 
with other lesions of giant cells (7-9). 
The clinical behaviour of  CGCG varies from a slowly 
asymptomatic swelling to an aggressive lesion that manifests 
with pain, cortical perforation, and root resorption. The 
traditional treatment of CGCG has been local curettage. 
However, aggressive sub-types of CGCG show a tendency 
to recur and necessitate bone resection that may determine 
extensive defects in jaws (10).  The aim of this study is to 
report the case of  a patient with a recurrent CGCG in 
the mandible, managed by means of local bone resection 
and defect regeneration with a composite bone graft that 
consisted of autogenous bone, xenograft, and autologous 
platelet-rich plasma (PRP), and the dental restoration in a 
second phase with an implant-supported prosthesis.
 
CASE REPORT  
A 48-year-old woman presented to our department in April 
2000 with a history of 3 months of swelling and pain in the 
left body of the mandible. Three months before the patient 
had felt mobility in the second inferior left molar tooth. She 
had visited her dentist who carried out the first and second 
left molar teeth extractions. From then on a swelling invol-
ving the left body of the mandible was growing gradually. 
She reported no pain and no sensory disturbance of the left 
lower lip and chin. Intraoral examination revealed an ex-
pansive bony mass in the left mandibular vestibule from the 
second cuspid to the angle. Panoramic radiography showed 
a 2x3 cm radiolucent lesion with poorly defined borders in 
the left body of the mandible, adjacent to the image of se-
cond molar extraction (Fig 1). In computed tomography an 
expansible lesion was visualized perforating and destroying 
the buccal cortical bone (Fig 2). Intraoral biopsy performed 
revealed a large number of multinucleated giant cells, areas 
of  haemorrhage, hemosiderin in deposits, some reactive 
woven bone and osteoid. The diagnosis was compatible 
with CGCG (Fig 3). Laboratory values for serum calcium, 
phosphorous, alkaline phosphate and PTH were within 
normal limits as were the blood cells count, excluding the 
brown tumour of  the hyperparathyroidism. The patient 
underwent curettage of the lesion followed by removal of 
the peripheral bony margins through a retromolar approach. 
The postoperative course of the patient was uneventful. 
Twelve months later a 1 cm of diameter ill-defined radioluci-
dency was detected in the panoramic radiograph. The CT scan 
confirmed the recurrence of the lesion causing erosion of the 
lingual cortical bone of the left body of the mandible (Fig 4). 
Fig. 1. Preoperative panoramic radiography. Note the unilo-
culated appearance and poorly defined borders of the lesion 
adjacent to the image of extraction of the left second molar 
tooth. 
Fig. 2. Pre-operative axial computed tomography shows an 
expansive, radiolucent and osteolytic lesion destroying the 
buccal cortical bone.
Fig. 3. Aggregates of multinucleated giant cells and granula-
tion tissue dispersed among stromal cells (H-E. 40x).
Fig. 4. Axial computed tomography one year later de-
monstrates the lesion recurrence causing osteolysis of the 
mandible with loss of bone in medial cortex.
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In April 2001 the lesion was removed en bloc with a bony 
security margin of 0.5 cm. The patient received a composite 
graft of autogenous particulated bone harvested from the 
mandibular ramus of the left side, and of bioactive glass 
(Biogram®, 3i Implant Innovations Inc, Florida, USA). 50 
cc of venous blood was processed using double centrifuga-
tion technique (Platelet Concentrates Collection System 
PCCS; 3i Implant Innovations Inc, Florida, USA), and 
separated the two fractions. Before their application, the clot 
of PRP was activated by means of calcium chloride. The 
composite graft was mixed with the PRP and the mixture 
was set into the bony defect. The patient was discharged the 
same day, and did not refer any symptoms nor there were 
any postoperative complications. Histological examination 
of the excised lesion was reported again as CGCG. 
No evidence of  clinical and radiological recurrence was 
observed during  follow-up for 24 months. In April of 
2003, after ascertainment of  graft integration and bone 
formation by panoramic radiograph and CT (Fig 5), two 
Osseotite NT® (3i Implant Innovations Inc, Florida, USA) 
endoosseous implants were placed in the mandible, 5 mm in 
diameter and 13 and 11.5 mm long. Three months later, se-
cond-stage surgery was performed. Partial implant-suppor-
ted screw retained prosthesis was constructed. After 5 years, 
no recurrence of lesion has occurred (Fig 6). The patient 
was seen in maintenance and periodic hygiene checkups. She 
presented a high level of comfort and satisfaction.
DISCUSSION
The etiopathogenesis of the CGCG of jawbones has not 
been clearly established but it has been suggested that it is 
the result of an exacerbated reparative process related to 
previous trauma and intraosseous haemorrhage that trig-
gers the reactive granulomatous process (9,11). Donoff and 
Rosenberg (12)  discussed a case record of an uncomplicated 
extraction because of pericoronitis in the area of the lesion 
and claimed the local changes in the blood flow throughout 
the bone and local bone dysplasia could be probable etio-
logic factors. Unal et al (13) presented a 12 year-old girl 
CGCG in the mandible caused by a molar tooth extraction 
and explained the pathogenesis by a traumatic aetiology. 
In our case, we can assume that teeth extractions was the 
CGCG inciting injury since the lesion was evident and grew 
rapidly only after molar teeth extractions.
Although CGCGs are benign osseous lesions, some authors 
separate CGCG into two types, referring to its clinical and 
radiographic features: (a) Nonaggressive lesion is usually 
slowgrowing and asymptomatic, does not show cortical 
resorption by the lesion or root perforation in teeth affected, 
and it is significantly less likely to recur than the aggressive 
type (3); and (b) Aggressive lesions, is usually found in youn-
ger patients and is painful, grows rapidly, is larger overall, 
often causes cortical perforation and root resorption and has 
a tendency to recur (2). Predict the behaviour of CGGCs 
that will exhibit a higher risk of recurrence after treatment 
has been problematic. The rate of recurrence varies bet-
ween 13-49% (14). Whitaker and Waldron (4) reported a 
mean interval between diagnosis and initial treatment and 
treatment of a recurrence was 21 months, and stated that 
very few recurrences were manifested after 2 years of initial 
treatment. The most reliable factors related to an increased 
risk of recurrence include clinical activity of lesions (72% 
of recurrence in the aggressive forms, 3% of recurrence in 
the nonaggressive forms), younger patients, demonstrated 
perforation of cortical bone and tumour size (15-17). There 
has been studies suggesting that the greater functional sur-
face area occupied by giant cells and larger relative size of 
giant cells may identify tumours with aggressive behaviour 
(2,8). Recently, Kruse-Loser et al (17) also proved that the 
aggressive variant of CGCG presented a high number of 
giant cells, an increased mitotic activity, and a high frac-
tional surface area. However, other studies have not been 
able to predict the clinical course of CGCGs from known 
histological or immunohistochemical features (11).  
GCGC is considered a non reparative lesion that destroys 
and grows if  it is not treated. Traditionally management 
has been surgical by means of excision by curettage, whi-
ch has been associated with a low recurrence rate in the 
well- located lesions (4,9,10,13). Curettage with peripheral 
ostectomy and bone resection is reserved for recurrences. 
Eisebund et al (3) used the technique of curettage or curetta-
ge plus peripheral ostectomy. Unal et al (13) recommended 
microdrill with diamond burr to obtain margins of security 
after removing the lesion and filled the cavity with iliac 
crest chips. The most aggressive or recurrent lesions can 
Fig. 5. Axial computed tomography two years later showing a 
well-healed and diseased-free mandible.
Fig. 6. (A) View of the implant-supported screw retained prosthesis and 
(B) panoramic radiography three years after implant placement.
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require en bloc bone resection and reconstruction, since 
it can determine a bone defect and teeth loss. Becelli et 
al (18) described a case treated by means of excision of a 
mandibular CGCG, reconstruction using autogenous iliac 
crest graft, dental implants and overdenture prosthesis. Non 
surgical approaches have been introduced, as administration 
intralesional corticoids (19), or systemic calcitonins that 
inhibit the osteoclastic activity (20). Other non surgical 
treatments include  interferon-alpha or bifosphonates 
(16,21). Conservative treatments have shown varying degrees 
of success and, when successful, have reduced the necessity 
for reconstructive surgery.
We initially used curettage and peripheral ostectomy to 
obtain clear surgical margins. When we detected the CGCG 
recurrence one year later, we carried out an en bloc resection. 
However, there are no published articles in the literature 
which refer to the employment of a bone graft combined 
of  autogenous bone and xenograft mixed with PRP for 
regeneration of the defect after resection of a CGCG recu-
rrence in the mandible. The ascending ramus of mandible 
represents an alternative source for obtaining particulated 
autogenous bone for small reconstructions in oral surgery, 
relatively simple to carry out, with a low complications rate 
(22). It can be mixed easily with xenografts and with PRP. 
It seems to be that the addiction of PRP accelerates soft 
tissues healing and favours bone regeneration especially 
when using composite bone graft, acting as a scaffold to 
support new bone formation (23,24). 
In our patient, CT scan showed an adequate new bone 
formation 24 months later. Bone density assessed during 
insertion of dental implants demonstrated that the newly 
formed bone had even higher density than bone commonly 
found in posterior mandible. Two dental implants were 
successfully placed and loaded, and an implant-supported 
prosthesis was constructed, providing a satisfactory dental 
restoration. A check up was carried out every 3 months 
from then on. At each visit a check on the restoration was 
made and the prosthesis was unscrewed to examine oral 
mucosa and bone.
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